Canopy Growth (WEED) Stock Forecast & Price Target

Canopy Growth - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce

Based on 4 Analyst Ratings

Sell
2

Hold
2

Buy
0

Consensus Price Target

C$7.12
N/A

Get the Latest News and Ratings for WEED and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Canopy Growth and its competitors.

WEED Analyst Ratings Over Time

Type	Current Forecast 12/5/23 to 12/4/24	1 Month Ago 11/5/23 to 11/4/24	3 Months Ago 9/6/23 to 9/5/24	1 Year Ago 12/5/22 to 12/5/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	3 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	C$7.12	C$7.12	C$6.45	C$1.56
Forecasted Upside	N/A	-7.07% Downside	0.84% Upside	73.56% Upside
Consensus Rating	Reduce	Reduce	Reduce	Reduce

The Crypto Secret Wall Street Doesn’t Want You to Know (Ad)

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

WEED Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WEED Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Canopy Growth Stock vs. The Competition

Type	Canopy Growth	Medical Companies
Consensus Rating Score	1.50	2.81
Consensus Rating	Reduce	Moderate Buy
News Sentiment Rating	Positive News See Recent WEED News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/12/2024	Canaccord Genuity Group 4 of 5 stars	Lower Target	Sell	C$5.00 ➝ C$3.50	-60.23%
6/18/2024	ATB Capital 4 of 5 stars	Set Target	Sector Perform	C$10.00	+2.88%
6/11/2024	Jefferies Financial Group 2 of 5 stars	Boost Target	Hold	C$4.90 ➝ C$10.63	+6.94%
6/4/2024	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		C$6.00 ➝ C$11.00	+3.38%
5/31/2024	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Underperform	C$4.50 ➝ C$4.00	-65.46%
2/14/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		C$7.00 ➝ C$4.00	-15.43%
Get the Latest News and Ratings for WEED and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.
1/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		C$1.49 ➝ C$6.70	+4.04%
9/15/2023	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		C$0.70 ➝ C$1.80	-1.10%
2/10/2023	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		C$2.00	-32.66%
2/10/2023	Eight Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		C$2.75 ➝ C$1.75	-41.08%
2/10/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		C$2.90 ➝ C$2.40	-19.19%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:52 AM ET.

WEED Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Canopy Growth is C$7.12, with a high forecast of C$11.00 and a low forecast of C$3.50.
: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" WEED shares.
: According to analysts, Canopy Growth's stock has a predicted upside of ∞ based on their 12-month stock forecasts.
: Analysts like Canopy Growth less than other "medical" companies. The consensus rating for Canopy Growth is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how WEED compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

This page (TSE:WEED) was last updated on 12/4/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canopy Growth (WEED) Stock Forecast & Price Target